~~<i id='34BB2167FC'><strike id='34BB2167FC'><tt id='34BB2167FC'><pre id='34BB2167FC'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：hotspot 2025-10-01 17:16:24 Page View：56

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Texas Department of Public Safety speaks out on migrant abuse allegations
Next article： Activists slam private health insurers over coverage restrictions

leisure time

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Divers poised to search for children washed away in Pennsylvania flash flood

1:17FloodingisseenhereinNewtownPennsylvaniaaftersomeseverestorms,July16,2023.ABCNewsDiverswerepoised

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Flu, Covid vaccination rates decline, new survey data show

JustinSullivan/GettyImagesVaccinationratesagainstfluandCovid-19havedeclinedsinceearlierinthepandemic